Dan Sheng
Director/Board Member at BEIJING STRONG BIOTECHNOLOGIES,INC.
Net worth: 907 594 $ as of 2024-04-29
Dan Sheng active positions
| Companies | Position | Start | End |
|---|---|---|---|
| BEIJING STRONG BIOTECHNOLOGIES,INC. | Director/Board Member | 2020-08-12 | - |
| Corporate Officer/Principal | 2016-11-30 | - | |
Fuzhou Maixin Biotech Co., Ltd.
 Fuzhou Maixin Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Part of Beijing Strong Biotechnologies, Inc., Fuzhou Maixin Biotech Co., Ltd. engages in the production, research & development, and sales of tissue-based diagnostics, specifically IHC antibodies, reagents, and the automation of IHC and ISH. The company is based in Fuzhou, China. Fuzhou Maixin Biotech Co. was acquired by Fuzhou Maixin Biotech Co. Ltd. /Private Group/ on September 30, 2020 for $255.21 million. The Chinese company was founded in 1993. The CEO is Xiao Ya Wang. | Director/Board Member | 2020-09-29 | - |
Career history of Dan Sheng
Training of Dan Sheng
| University of Science & Technology of China | Undergraduate Degree |
| New York University | Doctorate Degree |
| The University of Chicago | Masters Business Admin |
Statistics
International
| China | 4 |
| United States | 3 |
Operational
| Director/Board Member | 2 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sectoral
| Consumer Services | 4 |
| Health Services | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| BEIJING STRONG BIOTECHNOLOGIES,INC. | Health Technology |
| Private companies | 1 |
|---|---|
Fuzhou Maixin Biotech Co., Ltd.
Fuzhou Maixin Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Part of Beijing Strong Biotechnologies, Inc., Fuzhou Maixin Biotech Co., Ltd. engages in the production, research & development, and sales of tissue-based diagnostics, specifically IHC antibodies, reagents, and the automation of IHC and ISH. The company is based in Fuzhou, China. Fuzhou Maixin Biotech Co. was acquired by Fuzhou Maixin Biotech Co. Ltd. /Private Group/ on September 30, 2020 for $255.21 million. The Chinese company was founded in 1993. The CEO is Xiao Ya Wang. | Health Services |
- Stock Market
- Insiders
- Dan Sheng
- Experience
